Role of neuropeptide QRFP in the hypothalamus

Abstract

In the course of this paper, the problem of food consumption and weight regulation will be addressed. According to recent WHO statistics, 7.8% of population worldwide suffer from eating disorders, such as anorexia nervosa, bulimia nervosa or binge eating [1]. Often such patients reveal associated psychiatric symptoms: mood and anxiety disorders, substance abuse [2, 3], not mentioning frustratingly high suicide incidence [4, 5]. At the same time, up to 40% of world’s adult population are overweight, of these 13% were diagnosed with obesity [6]. Metabolic comorbidities, such as diabetes mellitus type 2, dysfunctions of gastro-intestinal tract and cardiovascular diseases, often accompany weight gain or loss and require special treatment [7- 11]. The topic of memory and learning processes will be another focus of this research. “There are over 9.9 million new cases of dementia each year worldwide, implying one new case every 3.2 seconds” – states Alzheimer’s disease international. The economic impact of dementia is greater than cancer and heart diseases combined [12]. For the patients with dementia, diagnosis attracts other health impacts and social isolation.